Experience

Experience

Securing $240 million and a jury verdict of willful infringement for Promptu in patent case against Comcast

Promptu Systems Corporation

US Synthetic secures ITC exclusion order barring polycrystalline diamond compacts (PDCs)

US Synthetic Corporation

Achieving precedent in preserving valuable patents for Lumify®

Eye Therapies, LLC

Finnegan client Maglula delivers crushing blow to Amazon’s arbitration practices over counterfeit products

Maglula, Ltd.

Finnegan secures $180M for CSRC in complex arbitrations

CSRC et al.

Protecting a blockbuster diabetes treatment for AstraZeneca

AstraZeneca AB

Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini

Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.

Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement

Eisai Co., Ltd.

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Recent Experience

Professional

Litigation Experience With

Experience

Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof

337-TA-1447, ITC, Judge Cheney

Experience

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Intellia Therapeutics, Inc.

Experience

Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al. Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.

1:21-cv-01736, 1:23-cv-00554, D. Del., Judge Andrews

Experience

Representative Engagement: Protecting a blockbuster diabetes treatment for AstraZeneca - AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc., 1:18-cv-00664, D. Del.

Protecting a blockbuster diabetes treatment for AstraZeneca Protecting a blockbuster diabetes treatment for AstraZeneca

1:18-cv-00664, D. Del., Judge Andrews

Experience

Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al. Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.

1:21-cv-00870, D. Del., Judge Hall

Experience

Representative Engagement: Finnegan revives key Jublia® patent at the Federal Circuit - Kaken Pharmaceutical Co., Ltd. et al v. Iancu, 18-2232, Fed. Cir.

Finnegan revives key Jublia® patent at the Federal Circuit Finnegan revives key Jublia® patent at the Federal Circuit

3:18-cv-13635, D.N.J., Judges Martinotti, Goodman
18-2232, Fed. Cir., Judges Newman, O'Malley, Taranto
IPR2017-00190, PTAB, Judges Mitchell, Franklin, Pollock
IPR2017-01429, PTAB, Judges Mitchell, Franklin, Pollock

Experience

Nissei ASB Co., et al. v. R&D Tool & Engineering Co. Nissei ASB Co., et al. v. R&D Tool & Engineering Co.

4:19-cv-00042, W.D. Mo., Judge Kays

Experience

Ajinomoto Co., Inc. et al. v. CJ Cheiljedang Corp. et al. Ajinomoto Co., Inc. et al. v. CJ Cheiljedang Corp. et al.

1:16-cv-03498, S.D.N.Y., Judges Gorenstein, Vyskocil
337-TA-1005, ITC, Judges Bullock, Essex
18-1590, -1629, Fed. Cir., Judges Dyk, Moore, Taranto
IPR2017-01551, -01698, PTAB, Judges Franklin, Mitchell, Moore, Sawert, Yang

Experience

District court finds patent covering AstraZeneca’s type II diabetes drugs Onglyza® and Kombiglyze® valid in ANDA litigation - (1:14-cv-00664, D. Del., IPR2015-01340, PTAB)

District court finds patent covering AstraZeneca’s type II diabetes drugs Onglyza^® and Kombiglyze^® valid in ANDA litigation District court finds patent covering AstraZeneca’s type II diabetes drugs Onglyza^® and Kombiglyze^® valid in ANDA litigation

1:14-cv-00664, D. Del., Judge Sleet
IPR2015-01340, PTAB, Judges Elluru, Paulraj, Tierney

Experience

Shionogi Pharmaceuticals v. Apotex/Sandoz Shionogi Pharmaceuticals v. Apotex/Sandoz

3:15-cv-00668, D.N.J., Judges Goodman, Sheridan
3:12-cv-07907, D.N.J., Judges Goodman, Hillman, Williams, Wolfson

Experience

AstraZeneca Pharmaceuticals LP, Shionogi Co. v. Watson Pharmaceuticals, Inc. AstraZeneca Pharmaceuticals LP, Shionogi Co. v. Watson Pharmaceuticals, Inc.

1:10-cv-00915, D. Del., Judge Stark

Experience

U.S. Court finds patent covering AstraZeneca’s anti-cholesterol drug Crestor®, is valid and enforceable in ANDA litigation U.S. Court finds patent covering AstraZeneca’s anti-cholesterol drug Crestor®, is valid and enforceable in ANDA litigation

1:08-md-01949, D. Del., Judges Farnan, Stark
10-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473, Fed. Cir., Judges Mayer, Newman, Plager